Skip to main content
. 2011 Dec 5;6(12):e27907. doi: 10.1371/journal.pone.0027907

Figure 2. Women's Access to Dual ART regimen for PMTCT or HAART as treatment based on the availability of CD4 results and CD4 Count<200 (n = 630).

Figure 2